These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 13836687)
41. Isolation and characterization of a bacteriophage and its potential to disrupt multi-drug resistant Pseudomonas aeruginosa biofilms. Yuan Y; Qu K; Tan D; Li X; Wang L; Cong C; Xiu Z; Xu Y Microb Pathog; 2019 Mar; 128():329-336. PubMed ID: 30682523 [TBL] [Abstract][Full Text] [Related]
42. Bacteriophage-based therapy in cystic fibrosis-associated Pseudomonas aeruginosa infections: rationale and current status. Hraiech S; Brégeon F; Rolain JM Drug Des Devel Ther; 2015; 9():3653-63. PubMed ID: 26213462 [TBL] [Abstract][Full Text] [Related]
43. [Experimental inhibition of growth of bacteria during the development of bacteriophage in Pseudomonas pyocyanea]. JACOB F C R Hebd Seances Acad Sci; 1951 Apr; 232(17):1605-7. PubMed ID: 14831264 [No Abstract] [Full Text] [Related]
44. The effect of bacteriophage on the respiration of E. coli and PS aeruginosa. HOLLIMAN FG; VAN DEN ENDE M; KAPLAN C; MACPHERSON CR S Afr J Clin Sci; 1952 Jun; 3(2):66-76. PubMed ID: 14950360 [No Abstract] [Full Text] [Related]
45. Effects of radiation on transduction on Pseudomonas aeruginosa. HOLLOWAY BW; MONK M; HODGINS L; FARGIE B Virology; 1962 Sep; 18():89-94. PubMed ID: 13908473 [No Abstract] [Full Text] [Related]
46. THE STRUCTURE OF PSEUDOMONAS AERUGINOSA PHAGES B3, E79, AND F116. SLAYTER HS; HOLLOWAY BW; HALL CE J Ultrastruct Res; 1964 Oct; 11():274-81. PubMed ID: 14230090 [No Abstract] [Full Text] [Related]
47. Bacteriophage Delivery by Nebulization and Efficacy Against Phenotypically Diverse Pseudomonas aeruginosa from Cystic Fibrosis Patients. Sahota JS; Smith CM; Radhakrishnan P; Winstanley C; Goderdzishvili M; Chanishvili N; Kadioglu A; O'Callaghan C; Clokie MR J Aerosol Med Pulm Drug Deliv; 2015 Oct; 28(5):353-60. PubMed ID: 25714328 [TBL] [Abstract][Full Text] [Related]
48. [The effect of carbon diet on the development of bacteriophages in Pseudomonas pyocyanea]. JACOB F Ann Inst Pasteur (Paris); 1952 May; 82(5):578-602. PubMed ID: 12976765 [No Abstract] [Full Text] [Related]
49. NUCLEIC ACID COMPOSITION OF A PSEUDOMONAS AERUGINOSA BACTERIOPHAGE. GROGAN JB; JOHNSON EJ Virology; 1964 Oct; 24():235-7. PubMed ID: 14240398 [No Abstract] [Full Text] [Related]
50. Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury-a case report. Jennes S; Merabishvili M; Soentjens P; Pang KW; Rose T; Keersebilck E; Soete O; François PM; Teodorescu S; Verween G; Verbeken G; De Vos D; Pirnay JP Crit Care; 2017 Jun; 21(1):129. PubMed ID: 28583189 [No Abstract] [Full Text] [Related]
51. The action of plant extracts on a bacteriophage of Pseudomonas pyocyanea and on influenza A virus. CHANTRILL BH; COULTHARD CE; DICKINSON L; INKLEY GW; MORRIS W; PYLE AH J Gen Microbiol; 1952 Feb; 6(1-2):74-84. PubMed ID: 14927853 [No Abstract] [Full Text] [Related]
52. Antibiofilm potential of purified environmental bacteriophage preparations against early stage Pseudomonas aeruginosa biofilms. Issa R; Chanishvili N; Caplin J; Kakabadze E; Bakuradze N; Makalatia K; Cooper I J Appl Microbiol; 2019 Jun; 126(6):1657-1667. PubMed ID: 30825355 [TBL] [Abstract][Full Text] [Related]
53. Bacteriophage therapy for refractory Pseudomonas aeruginosa urinary tract infection. Khawaldeh A; Morales S; Dillon B; Alavidze Z; Ginn AN; Thomas L; Chapman SJ; Dublanchet A; Smithyman A; Iredell JR J Med Microbiol; 2011 Nov; 60(Pt 11):1697-1700. PubMed ID: 21737541 [TBL] [Abstract][Full Text] [Related]
54. [Dynamics of the interaction between Pseudomonas aeruginosa bacteriophage phimF81 and host bacteria]. Balakshina VV; Kulakov LA; Boronin AM Mikrobiologiia; 1992; 61(6):1051-5. PubMed ID: 1297042 [TBL] [Abstract][Full Text] [Related]
55. Bacteriophages in sputum of cystic fibrosis patients as a possible cause of in vivo changes in serotypes of Pseudomonas aeruginosa. Ojeniyi B APMIS; 1988 Apr; 96(4):294-8. PubMed ID: 3130885 [TBL] [Abstract][Full Text] [Related]
56. [Effect of plasmids from various incompatibility groups on the development of bacteriophages specific to Pseudomonas aeruginosa and Pseudomonas putida]. Kulakov LA; Mazepa VN; Boronin AM Mikrobiologiia; 1984; 53(3):471-5. PubMed ID: 6431239 [TBL] [Abstract][Full Text] [Related]
57. Transduction of a plasmid containing the bacteriophage D3 cos site in Pseudomonas aeruginosa. Sharp R; Gertman E; Farinha MA; Kropinski AM J Bacteriol; 1990 Jun; 172(6):3509-11. PubMed ID: 2111812 [TBL] [Abstract][Full Text] [Related]
58. Changes in somatic antigens of Pseudomonas aeruginosa induced by bacteriophages. Liu PV J Infect Dis; 1969 Mar; 119(3):237-46. PubMed ID: 4976344 [No Abstract] [Full Text] [Related]
59. [Spontaneous and induced production of bacteriophages in polylysogenic Pseudomonas pyocyanea]. JACOB F Ann Inst Pasteur (Paris); 1952 Nov; 83(5):671-92. PubMed ID: 13017176 [No Abstract] [Full Text] [Related]